Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 3
2006 2
2007 8
2008 3
2010 6
2011 4
2012 1
2013 9
2014 10
2015 1
2017 5
2018 3
2019 3
2020 5
2021 4
2022 5
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
Wagenlehner FM, Gasink LB, McGovern PC, Moeck G, McLeroth P, Dorr M, Dane A, Henkel T; CERTAIN-1 Study Team. Wagenlehner FM, et al. N Engl J Med. 2024 Feb 15;390(7):611-622. doi: 10.1056/NEJMoa2304748. N Engl J Med. 2024. PMID: 38354140 Clinical Trial.
Carbapenem-resistant Gram-negative pathogens associated with septic shock: a review of 120 cases.
Önal U, Akyol D, Mert M, Başkol D, Memetali SC, Şanlıdağ G, Kenanoğlu B, Uyan-Önal A, Quliyeva G, Avşar CB, Akdağ D, Demir M, Erdem HA, Kahraman Ü, Bozbıyık O, Özgiray E, Bozkurt D, Akarca FK, Demirağ K, Çankayalı İ, Uyar M, Çilli F, Arda B, Yamazhan T, Pullukçu H, Taşbakan MI, Sipahi H, Ulusoy S, Sipahi OR. Önal U, et al. Among authors: yamazhan t. J Chemother. 2022 Nov;34(7):436-445. doi: 10.1080/1120009X.2022.2064703. Epub 2022 Apr 21. J Chemother. 2022. PMID: 35446235 Review.
Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter ephesus study.
Sipahi OR, Akyol D, Ormen B, Cicek-Senturk G, Mermer S, Onal U, Amer F, Saed MA, Ozdemir K, Tukenmez-Tigen E, Oztoprak N, Altin U, Kurtaran B, Popescu CP, Sakci M, Suntur BM, Gautam V, Sharma M, Kaya S, Akcil EF, Kaya S, Turunc T, Ergen P, Kandemir O, Cesur S, Bardak-Ozcem S, Ozgiray E, Yurtseven T, Erdem HA, Sipahi H, Arda B, Pullukcu H, Tasbakan M, Yamazhan T, Aydemir S, Ulusoy S. Sipahi OR, et al. Among authors: yamazhan t. BMC Infect Dis. 2023 Sep 28;23(1):639. doi: 10.1186/s12879-023-08596-z. BMC Infect Dis. 2023. PMID: 37770836 Free PMC article.
Telaprevir experience from Turkey.
Komur S, Kurtaran B, Inal AS, Pullukcu H, Ulu A, Kuscu F, Yamazhan T, Tasova Y, Aksu HS. Komur S, et al. Among authors: yamazhan t. Hepat Mon. 2015 Feb 18;15(2):e25639. doi: 10.5812/hepatmon.25639. eCollection 2015 Feb. Hepat Mon. 2015. PMID: 25788959 Free PMC article.
Brucellosis in pregnancy: results of multicenter ID-IRI study.
Inan A, Erdem H, Elaldi N, Gulsun S, Karahocagil MK, Pekok AU, Ulug M, Tekin R, Bosilkovski M, Kaya S, Haykir-Solay A, Demirdal T, Kaya S, Sunnetcioglu M, Sener A, Tosun S, Aydin E, Ural S, Yamazhan T, Muhcu M, Ayaslioglu E, Bilgic-Atli S, Erbay A, Ergen P, Kadanali A, Sahin S, Sahin-Horasan E, Avci A, Cag Y, Beeching NJ. Inan A, et al. Among authors: yamazhan t. Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1261-1268. doi: 10.1007/s10096-019-03540-z. Epub 2019 Apr 15. Eur J Clin Microbiol Infect Dis. 2019. PMID: 30989418
Antibiotic use and Influencing Factors Among Hospitalized Patients with COVID-19: A Multicenter Point-Prevalence Study from Turkey.
Şencan İ, Çağ Y, Karabay O, Kurtaran B, Güçlü E, Öğütlü A, Demirbaş Z, Bulut D, Karlıdağ GE, Sefa Sayar M, Şibar EG, Eren Kutsoylu OÖ, Kul G, Erol S, Bektaş B, Ünver Ulusoy T, Kuzi S, Tasbakan M, Yiğit Ö, Ceran N, İnal AS, Ergen P, Yamazhan T, Uzar H, Ağalar C. Şencan İ, et al. Among authors: yamazhan t. Balkan Med J. 2022 May 24;39(3):209-217. doi: 10.4274/balkanmedj.galenos.2022.2021-11-62. Balkan Med J. 2022. PMID: 35611705 Free PMC article.
Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: an analysis of 53 cases.
Önal U, Akyol D, Kaya A, Başkol D, Kenanoglu B, Şanlıdağ G, Önal AU, Avşar CB, Mert M, Memetali S, Erdem HA, Bozkurt D, Şimşir A, Bozbıyık O, Kahraman Ü, Özgiray E, Korkmaz P, Çilli F, Pullukçu H, Yamazhan T, Taşbakan MI, Arda B, Ulusoy S, Sipahi OR. Önal U, et al. Among authors: yamazhan t. Eur J Clin Microbiol Infect Dis. 2023 Oct;42(10):1269-1273. doi: 10.1007/s10096-023-04660-3. Epub 2023 Sep 7. Eur J Clin Microbiol Infect Dis. 2023. PMID: 37676420
75 results